ClinicalTrials.gov
public full text
Public Domain
Effects of Niaspan™ on High-density Lipoprotein (HDL) in Healthy Male Subjects (0000-069)
This study will evaluate whether chronic dosing with Niaspan™ increases reverse cholesterol transport, high-density lipoprotein cholesterol (HDL-C) levels, and fecal excretion of cholesterol.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- MK0524A Clinical Efficacy Study (0524A-026)(COMPLETED)#828279
- Effect of Niacin on Transport of HDL and Relationship to Atherogenic Lipoproteins and Lipolysis#897405
- Effects of Niacin Therapy on Lipoprotein Composition and Function#803245
- First-in-Human Study With GNbAC1 in Healthy Volunteers#842754
- Absorption and Tolerability of Injectable Administration of Niagen®+, as Compared to NAD+#866709
Record · ID 1058771
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive